Home/Filings/4/0001209191-22-060128
4//SEC Filing

Romano Kelly A 4

Accession 0001209191-22-060128

CIK 0001620463other

Filed

Dec 5, 7:00 PM ET

Accepted

Dec 6, 8:31 PM ET

Size

5.0 KB

Accession

0001209191-22-060128

Insider Transaction Report

Form 4
Period: 2022-12-02
Transactions
  • Purchase

    Common Stock

    2022-12-02$3.29/sh+30,000$98,70038,315 total
Footnotes (1)
  • [F1]The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.23 to $3.31, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.

Issuer

Athira Pharma, Inc.

CIK 0001620463

Entity typeother

Related Parties

1
  • filerCIK 0001722055

Filing Metadata

Form type
4
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 8:31 PM ET
Size
5.0 KB